21/06/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

21/06/2024

Jun 21, 2024, 12:55 | Insight
Akash Maniam: Abstract submission for 2nd International Urology Cancer Summit will close on June 30th
Akash Maniam, Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared on LinkedIn: “If you…
Jun 21, 2024, 12:43 | Insight
The new ESMO Clinical Practice Guideline is now available
European Society for Medical Oncology (ESMO) shared on LinkedIn:  “The new ESMO Clinical Practice Guideline…
Jun 21, 2024, 12:28 | Insight
Paolo Tarantino: The CAPItello290 trial did not meet the dual primary endpoints
Paolo Tarantino shared on X/Twitter: "Press Release: the CAPItello290 trial of 1L paclitaxel +/- capivasertib in…
Jun 21, 2024, 12:25 | Blog
Sanam Loghavi: Another day in the life of a hematopathologist
Sanam Loghavi shared on X/Twitter: "Another day in the life of a hematopathologist….. To say I…
Jun 21, 2024, 12:21 | Blog
Fumiko Ladd Chino: We're going to usher in a new era of multidisciplinary leadership!
Fumiko Ladd Chino shared on X/Twitter: "Of note, MD Anderson Cancer Center will have 2 RadOnc…
Jun 21, 2024, 12:12 | Blog
The Hospital Research Foundation Group - $195,000 GRANT announcement for bowel cancer research
The Hospital Research Foundation Group shared a post on LinkedIn: "Exciting GRANT announcement!! June is Bowel…
Jun 21, 2024, 12:11 | Blog
Episode 13 of Hematopoiesis - ASH
ASH shared on X/Twitter: "ASH Trainee Council Members Dr. Emily Liang and Dr. Ajay Major…
Jun 21, 2024, 11:58 | Blog
Tulsi Jose: H.O.M.E Mentorship is looking for new mentors
Tulsi Jose shared a post on X: "H.O.M.E Mentorship is looking for NEW mentors. We paired…
Jun 21, 2024, 11:57 | Blog
Elad Sharon: Two of my major trials led to FDA Oncology approvals
Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared on X/Twitter: "Past week,…
Jun 21, 2024, 11:16 | Insight
Paolo Tarantino: Phase 1 trial of the MMAF-based, HER2-targeting ADC FS-1502 published in Nature Communications
Paolo Tarantino shared on X/Twitter: "Phase 1 trial of the MMAF-based, HER2-targeting ADC FS-1502 published…
All: 103 Posts: 41 - 50
Special Coverage